ProCE Banner Activity

The Promise of Long-Acting Injectable Antiretroviral Therapies

Clinical Thought
Will long-acting cabotegravir plus rilpivirine injections satisfy patient desire for less frequent dosing? Here is my take.

Released: April 12, 2017

Expiration: April 11, 2018

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

ViiV Healthcare